Navigation Links
Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities
Date:11/20/2007

Coalition of Patient and Consumer Groups calls for Legislative Action to

Ensure Access to 'Off-Label' Drug Treatments

WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- Twenty-six patient, family caregiver and health professional organizations are calling upon Congress to pass legislation to require Medicare prescription drug plans to provide access to all medically accepted uses for the drugs they cover.

Medicare regulations exclude Part D coverage of a medication if it is prescribed for a use that is not on the Food and Drug Administration (FDA) label or supported by a citation in one of three specific medical compendia. In a sign-on letter to the Senate, the organizations wrote that the "exclusive reliance on FDA indications and a limited number of compendia prevents access to medically necessary, life-sustaining prescriptions."

Over 20 percent of the 500 most commonly prescribed drugs are used for off-label treatments. According to the letter, "People with cancer, HIV/AIDS, lupus, multiple sclerosis, debilitating pain, and mental health conditions, and other rare and serious conditions are routinely prescribed drugs off-label to manage disease symptoms and progression." The letter is available at http://www.medicarerights.org/maprxlettertobaucus.pdf

"We know of a number of people who have been hospitalized or been required to take other more expensive treatments because they did not have access to their prescribed medicines," said Andrew Sperling, Director of Legislative Advocacy, National Alliance on Mental Illness.

For specific cases and more information, see the Medicare Rights Center's report, "Off-Base: The Exclusion of Off-Label Prescriptions from Medicare Part D Coverage," available at http://www.medicarerights.org/Off-label_PartD_Coverage.pdf

Medicare's Part D regulations on off-label use are inconsistent with the more expansive Part B regulations, which allow for consideration of evidence of effectiveness in peer-reviewed literature in addition to the FDA label and the compendia. Part B's prescription drug coverage includes certain injectable cancer drugs and immunosuppressive drugs.

"As HIV clinicians, we are asking for the ability to present published data during the exceptions process that would demonstrate compelling evidence that an individual patient would benefit from treatments that cannot be covered by Medicare Part D programs under the current rules," said Bruce Williams, MD, MPH, a member of the HIV Medicine Association. "Often the debilitating effects of HIV or its treatments are best treated with medications that may not have been approved specifically for people with HIV/AIDS or for a specific condition, despite strong evidentiary support for the use in the medical literature."

The sign-on letter specifically urges Congress to amend the Medicare statutes to make Part D coverage of off-label uses consistent with Part B, allowing for consideration of peer-reviewed literature in determining coverage.

Medical Access for Patients Rx (MAPRx), a coalition of patient, family caregiver and health professional organizations, is working with other allied groups to build support for a Congressional action on this issue.

MAPRx is a coalition of patient, family caregiver and health professional organizations committed to safeguarding the well-being of patients with chronic diseases and disabilities under Medicare Prescription Drug Coverage. MAPRx member organizations collaborate with national and state policymakers to ensure that beneficiaries have the access to the medication therapies they need and deserve.

http://www.maprx.info


'/>"/>
SOURCE MAPRx
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
2. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
3. Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions
4. Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
5. CEL-SCI Corporation Releases Letter to Shareholders
6. Aspirin Named 8th World Wonder by Majority of Americans
7. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
8. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
9. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
11. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... -- Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices Market Outlook to 2022", provides ... Devices market. The report provides value, in millions ... prices (USD) within market segement - Glaucoma Drainage ... and distribution shares data for each of these ...
(Date:12/8/2016)... 2016 KEY FINDINGS The global ... 2017-2023. Various reasons for growth of the medical lifting ... of chronic diseases, high recovery cost of injuries and ... Medical lifting sling refers to an assistive device that ... slings connect to the lift and hold the patient. ...
(Date:12/8/2016)... Lilly and Company (NYSE: LLY ) today ... at the 9 th Clinical Trials on Alzheimer,s ... meet the primary endpoint in the EXPEDITION3 clinical trial, ... dementia due to Alzheimer,s disease (AD), and Lilly will ... of mild dementia due to AD. ...
Breaking Medicine Technology:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... miniature, folded, pharmaceutical inserts and outserts. As a means of expanding capabilities ... addition will enable Flottman to individually code professional inserts (PIs) and patient package ...
(Date:12/9/2016)... NY (PRWEB) , ... December 09, 2016 , ... ... and Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits ... and the District of Columbia as an education tool in the war against teen ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted ... all types of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves ... use and could be set up in a matter of minutes, or even seconds. ...
(Date:12/9/2016)... ... 09, 2016 , ... The Holy Name Medical Center Foundation ... on December 3rd, to benefit Holy Name Medical Center's programs and services. More ... over $1 million - the largest event in the Center's history, both in ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying to get ... thought that if the nebulizer had a more child-friendly design, then children would be ... developed the patent-pending NEBY to avoid the need to deliver medication via a nebulizer ...
Breaking Medicine News(10 mins):